{
  "docId": "019de518-6502-70bc-9a44-c6a9c7f323b5",
  "docSlug": "4230ce80abe7092521a593effe59cbcd",
  "documentTitle": "Oculis | Investor Presentation Deck | 48 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 48,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de518-6502-70bc-9a44-c6a9c7f323b5/25",
  "deckHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5",
  "deckJsonHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5.json",
  "deckAnchorHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.09,
        "w": 0.47,
        "x": 0.49,
        "y": 0.74
      },
      "kind": "callout",
      "text": "Only 13% of patients feel that their chronic dry eye is well-managed³",
      "attrs": {},
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "567e3da9-d532-4e17-92f8-7541c397cff9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.47,
        "x": 0.49,
        "y": 0.58
      },
      "kind": "callout",
      "text": "~13% of diagnosed patients with DED are being treated with a prescription medicine in the US²",
      "attrs": {},
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4c626c4-69e2-4c9d-a805-0b7645527a1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.94,
        "x": 0.026,
        "y": 0.29
      },
      "kind": "diagram",
      "text": "Rx Treatments¹\n2002\nRestasis\n(Cyclosporine Ophthalmic Emulsion) 0.05%\n2016\nXiidra\n(lifitegrast\nophthalmic solution)5%\n2018\nCequa\n(cyclosporine ophthalmic solution) 0.09%\n2020\nEYSUVIS\n(loteprednol etabonate\nophthalmic suspension) 0.25%\n2021\ntyrvaya\n(varenicline solution)\nnasal spray 0.03 mg\n2023\nNEW!\nMiebo\n(perfluorohexyloctane\nophthalmic solution)\nvevye\n(cyclosporine ophthalmic\nsolution) 0.1%",
      "attrs": {},
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "606eba76-c8ee-43be-96b2-93e692454a48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.11,
        "x": 0.85,
        "y": 0.03
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98184aa8-0495-4caf-adc2-0e734a968585",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.32,
        "w": 0.22,
        "x": 0.03,
        "y": 0.55
      },
      "kind": "list",
      "text": "OTC tears\nSystane\nGenTeal Tears\nRefresh\n...and countless more...",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "118e3101-5260-47e9-8dbe-98b5e9d33c27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.32,
        "w": 0.22,
        "x": 0.24,
        "y": 0.55
      },
      "kind": "list",
      "text": "In-office procedures\nTearCare\nLIPIFLOW\nOptiLight\n...and countless more...",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a1f16f5f-00e4-4e1d-b7c1-3e3a84e16fd6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.026,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "DED (Dry eye disease).\n1. Downs P. 2023 Dry Eye Products Market Report, Global Analysis for 2022 to 2028. Market Scope; 2023. 2. Jain H, et al. Dry eye disease landscape and forecast. Decision Resources Group (DRG); 2020.\n3. Health Union Community Editorial Team. 2021 In America Survey Findings: Living With Chronic Dry Eye. Chronic Dry Eye. 2021. https://chronicdryeye.net/infographic/in-america-findings.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecda5df3-c525-4bc7-9ee6-139f8c9ea0a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.52,
        "x": 0.026,
        "y": 0.06
      },
      "kind": "title",
      "text": "Despite New Treatment Options, Patient Satisfaction Remains a Challenge",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52c3c972-a967-49cd-b647-869860334cc6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 26,
      "from": 25,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "37af4b1c-48e4-4653-b14d-5d618b4e8ff7",
      "evidence": "The document presents the limitations of current treatments for dry eye disease",
      "position": 0,
      "objective": "Highlight the unmet need for novel treatments for dry eye disease",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}